Global Neurogenetic Testing Market Research Report 2026(Status and Outlook)
Neurogenetic testing is a molecular and genomic diagnostic approach used to analyze and interpret genes associated with neurological disorders. This testing helps identify whether an individual carries genetic mutations that may cause neurodegenerative diseases, epilepsy, intellectual disability, autism spectrum disorders, movement disorders, and certain hereditary neuropathies. The value of neurogenetic testing lies not only in early disease screening and clinical diagnosis, but also in guiding physicians to develop personalized treatment plans and assisting families with genetic risk assessment and reproductive planning.Global neurogenetic testing players include Quest Diagnostics, Mayo Clinic, GeneDx, Illumina and Labcorp, etc. Global top five manufacturers hold a share about 30%.The largest market is North America, has a share over 30%, followed by Europe and Asia Pacific, with around 32% and 20% market share respectively.In terms of product, Exome Sequencing is the largest segment, with a share about 45%. And in terms of application, the largest application is Hospitals, has a share over 45%, followed by Specialty Clinics, Research Institutes and Diagnostics Laboratories.With the growing clinical burden of diseases such as Alzheimer?s, Parkinson?s, epilepsy, and autism spectrum disorders, genetic testing is becoming a critical tool for early diagnosis, risk prediction, and personalized treatment. Advances in next-generation sequencing (NGS), whole-exome sequencing (WES), and whole-genome sequencing (WGS) have significantly reduced costs while improving accuracy and efficiency, accelerating adoption in clinical practice. At the same time, pharmaceutical companies and healthcare providers are increasingly integrating neurogenetic testing into drug development and clinical trials to identify potential therapeutic targets and companion diagnostics.
The global Neurogenetic Testing market size was estimated at USD 685.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 11.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neurogenetic Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neurogenetic Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neurogenetic Testing market.
Global Neurogenetic Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Quest Diagnostics
Mayo Clinic
GeneDx
Illumina
Labcorp (Invitae/MNG Laboratories)
MedGenome Labs
Connecticut Children's
CENTOGENE
Victorian Clinical Genetics Services
PacBio
Market Segmentation (by Type)
Exome Sequencing
Whole Genome Sequencing
RNA Sequencing
General DNA Testing
Market Segmentation (by Application)
Hospitals
Specialty Clinics
Research Institutes
Diagnostics Laboratories
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neurogenetic Testing Market
Overview of the regional outlook of the Neurogenetic Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurogenetic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neurogenetic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Neurogenetic Testing market size was estimated at USD 685.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 11.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neurogenetic Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neurogenetic Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neurogenetic Testing market.
Global Neurogenetic Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Quest Diagnostics
Mayo Clinic
GeneDx
Illumina
Labcorp (Invitae/MNG Laboratories)
MedGenome Labs
Connecticut Children's
CENTOGENE
Victorian Clinical Genetics Services
PacBio
Market Segmentation (by Type)
Exome Sequencing
Whole Genome Sequencing
RNA Sequencing
General DNA Testing
Market Segmentation (by Application)
Hospitals
Specialty Clinics
Research Institutes
Diagnostics Laboratories
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neurogenetic Testing Market
Overview of the regional outlook of the Neurogenetic Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurogenetic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neurogenetic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neurogenetic Testing
1.2 Key Market Segments
1.2.1 Neurogenetic Testing Segment by Type
1.2.2 Neurogenetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROGENETIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROGENETIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neurogenetic Testing Product Life Cycle
3.3 Global Neurogenetic Testing Revenue Market Share by Company (2020-2025)
3.4 Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Neurogenetic Testing Market Competitive Situation and Trends
3.6.1 Neurogenetic Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurogenetic Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEUROGENETIC TESTING VALUE CHAIN ANALYSIS
4.1 Neurogenetic Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROGENETIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neurogenetic Testing Market Porter's Five Forces Analysis
6 NEUROGENETIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurogenetic Testing Market by Type (2020-2025)
6.3 Global Neurogenetic Testing Market Size Growth Rate by Type (2021-2025)
7 NEUROGENETIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurogenetic Testing Market Size (M USD) by Application (2020-2025)
7.3 Global Neurogenetic Testing Market Size Growth Rate by Application (2021-2025)
8 NEUROGENETIC TESTING MARKET SEGMENTATION BY REGION
8.1 Global Neurogenetic Testing Market Size by Region
8.1.1 Global Neurogenetic Testing Market Size by Region
8.1.2 Global Neurogenetic Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Neurogenetic Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurogenetic Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Neurogenetic Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurogenetic Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurogenetic Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Quest Diagnostics
9.1.1 Quest Diagnostics Basic Information
9.1.2 Quest Diagnostics Neurogenetic Testing Product Overview
9.1.3 Quest Diagnostics Neurogenetic Testing Product Market Performance
9.1.4 Quest Diagnostics SWOT Analysis
9.1.5 Quest Diagnostics Business Overview
9.1.6 Quest Diagnostics Recent Developments
9.2 Mayo Clinic
9.2.1 Mayo Clinic Basic Information
9.2.2 Mayo Clinic Neurogenetic Testing Product Overview
9.2.3 Mayo Clinic Neurogenetic Testing Product Market Performance
9.2.4 Mayo Clinic SWOT Analysis
9.2.5 Mayo Clinic Business Overview
9.2.6 Mayo Clinic Recent Developments
9.3 GeneDx
9.3.1 GeneDx Basic Information
9.3.2 GeneDx Neurogenetic Testing Product Overview
9.3.3 GeneDx Neurogenetic Testing Product Market Performance
9.3.4 GeneDx SWOT Analysis
9.3.5 GeneDx Business Overview
9.3.6 GeneDx Recent Developments
9.4 Illumina
9.4.1 Illumina Basic Information
9.4.2 Illumina Neurogenetic Testing Product Overview
9.4.3 Illumina Neurogenetic Testing Product Market Performance
9.4.4 Illumina Business Overview
9.4.5 Illumina Recent Developments
9.5 Labcorp (Invitae/MNG Laboratories)
9.5.1 Labcorp (Invitae/MNG Laboratories) Basic Information
9.5.2 Labcorp (Invitae/MNG Laboratories) Neurogenetic Testing Product Overview
9.5.3 Labcorp (Invitae/MNG Laboratories) Neurogenetic Testing Product Market Performance
9.5.4 Labcorp (Invitae/MNG Laboratories) Business Overview
9.5.5 Labcorp (Invitae/MNG Laboratories) Recent Developments
9.6 MedGenome Labs
9.6.1 MedGenome Labs Basic Information
9.6.2 MedGenome Labs Neurogenetic Testing Product Overview
9.6.3 MedGenome Labs Neurogenetic Testing Product Market Performance
9.6.4 MedGenome Labs Business Overview
9.6.5 MedGenome Labs Recent Developments
9.7 Connecticut Children's
9.7.1 Connecticut Children's Basic Information
9.7.2 Connecticut Children's Neurogenetic Testing Product Overview
9.7.3 Connecticut Children's Neurogenetic Testing Product Market Performance
9.7.4 Connecticut Children's Business Overview
9.7.5 Connecticut Children's Recent Developments
9.8 CENTOGENE
9.8.1 CENTOGENE Basic Information
9.8.2 CENTOGENE Neurogenetic Testing Product Overview
9.8.3 CENTOGENE Neurogenetic Testing Product Market Performance
9.8.4 CENTOGENE Business Overview
9.8.5 CENTOGENE Recent Developments
9.9 Victorian Clinical Genetics Services
9.9.1 Victorian Clinical Genetics Services Basic Information
9.9.2 Victorian Clinical Genetics Services Neurogenetic Testing Product Overview
9.9.3 Victorian Clinical Genetics Services Neurogenetic Testing Product Market Performance
9.9.4 Victorian Clinical Genetics Services Business Overview
9.9.5 Victorian Clinical Genetics Services Recent Developments
9.10 PacBio
9.10.1 PacBio Basic Information
9.10.2 PacBio Neurogenetic Testing Product Overview
9.10.3 PacBio Neurogenetic Testing Product Market Performance
9.10.4 PacBio Business Overview
9.10.5 PacBio Recent Developments
10 NEUROGENETIC TESTING MARKET FORECAST BY REGION
10.1 Global Neurogenetic Testing Market Size Forecast
10.2 Global Neurogenetic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurogenetic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Neurogenetic Testing Market Size Forecast by Region
10.2.4 South America Neurogenetic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Neurogenetic Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Neurogenetic Testing Market Forecast by Type (2026-2035)
11.1.1 Global Neurogenetic Testing Market Size Forecast by Type (2026-2035)
11.2 Global Neurogenetic Testing Market Forecast by Application (2026-2035)
11.2.1 Global Neurogenetic Testing Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neurogenetic Testing
1.2 Key Market Segments
1.2.1 Neurogenetic Testing Segment by Type
1.2.2 Neurogenetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROGENETIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROGENETIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neurogenetic Testing Product Life Cycle
3.3 Global Neurogenetic Testing Revenue Market Share by Company (2020-2025)
3.4 Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Neurogenetic Testing Market Competitive Situation and Trends
3.6.1 Neurogenetic Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurogenetic Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEUROGENETIC TESTING VALUE CHAIN ANALYSIS
4.1 Neurogenetic Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROGENETIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neurogenetic Testing Market Porter's Five Forces Analysis
6 NEUROGENETIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurogenetic Testing Market by Type (2020-2025)
6.3 Global Neurogenetic Testing Market Size Growth Rate by Type (2021-2025)
7 NEUROGENETIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurogenetic Testing Market Size (M USD) by Application (2020-2025)
7.3 Global Neurogenetic Testing Market Size Growth Rate by Application (2021-2025)
8 NEUROGENETIC TESTING MARKET SEGMENTATION BY REGION
8.1 Global Neurogenetic Testing Market Size by Region
8.1.1 Global Neurogenetic Testing Market Size by Region
8.1.2 Global Neurogenetic Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Neurogenetic Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurogenetic Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Neurogenetic Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurogenetic Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurogenetic Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Quest Diagnostics
9.1.1 Quest Diagnostics Basic Information
9.1.2 Quest Diagnostics Neurogenetic Testing Product Overview
9.1.3 Quest Diagnostics Neurogenetic Testing Product Market Performance
9.1.4 Quest Diagnostics SWOT Analysis
9.1.5 Quest Diagnostics Business Overview
9.1.6 Quest Diagnostics Recent Developments
9.2 Mayo Clinic
9.2.1 Mayo Clinic Basic Information
9.2.2 Mayo Clinic Neurogenetic Testing Product Overview
9.2.3 Mayo Clinic Neurogenetic Testing Product Market Performance
9.2.4 Mayo Clinic SWOT Analysis
9.2.5 Mayo Clinic Business Overview
9.2.6 Mayo Clinic Recent Developments
9.3 GeneDx
9.3.1 GeneDx Basic Information
9.3.2 GeneDx Neurogenetic Testing Product Overview
9.3.3 GeneDx Neurogenetic Testing Product Market Performance
9.3.4 GeneDx SWOT Analysis
9.3.5 GeneDx Business Overview
9.3.6 GeneDx Recent Developments
9.4 Illumina
9.4.1 Illumina Basic Information
9.4.2 Illumina Neurogenetic Testing Product Overview
9.4.3 Illumina Neurogenetic Testing Product Market Performance
9.4.4 Illumina Business Overview
9.4.5 Illumina Recent Developments
9.5 Labcorp (Invitae/MNG Laboratories)
9.5.1 Labcorp (Invitae/MNG Laboratories) Basic Information
9.5.2 Labcorp (Invitae/MNG Laboratories) Neurogenetic Testing Product Overview
9.5.3 Labcorp (Invitae/MNG Laboratories) Neurogenetic Testing Product Market Performance
9.5.4 Labcorp (Invitae/MNG Laboratories) Business Overview
9.5.5 Labcorp (Invitae/MNG Laboratories) Recent Developments
9.6 MedGenome Labs
9.6.1 MedGenome Labs Basic Information
9.6.2 MedGenome Labs Neurogenetic Testing Product Overview
9.6.3 MedGenome Labs Neurogenetic Testing Product Market Performance
9.6.4 MedGenome Labs Business Overview
9.6.5 MedGenome Labs Recent Developments
9.7 Connecticut Children's
9.7.1 Connecticut Children's Basic Information
9.7.2 Connecticut Children's Neurogenetic Testing Product Overview
9.7.3 Connecticut Children's Neurogenetic Testing Product Market Performance
9.7.4 Connecticut Children's Business Overview
9.7.5 Connecticut Children's Recent Developments
9.8 CENTOGENE
9.8.1 CENTOGENE Basic Information
9.8.2 CENTOGENE Neurogenetic Testing Product Overview
9.8.3 CENTOGENE Neurogenetic Testing Product Market Performance
9.8.4 CENTOGENE Business Overview
9.8.5 CENTOGENE Recent Developments
9.9 Victorian Clinical Genetics Services
9.9.1 Victorian Clinical Genetics Services Basic Information
9.9.2 Victorian Clinical Genetics Services Neurogenetic Testing Product Overview
9.9.3 Victorian Clinical Genetics Services Neurogenetic Testing Product Market Performance
9.9.4 Victorian Clinical Genetics Services Business Overview
9.9.5 Victorian Clinical Genetics Services Recent Developments
9.10 PacBio
9.10.1 PacBio Basic Information
9.10.2 PacBio Neurogenetic Testing Product Overview
9.10.3 PacBio Neurogenetic Testing Product Market Performance
9.10.4 PacBio Business Overview
9.10.5 PacBio Recent Developments
10 NEUROGENETIC TESTING MARKET FORECAST BY REGION
10.1 Global Neurogenetic Testing Market Size Forecast
10.2 Global Neurogenetic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurogenetic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Neurogenetic Testing Market Size Forecast by Region
10.2.4 South America Neurogenetic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Neurogenetic Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Neurogenetic Testing Market Forecast by Type (2026-2035)
11.1.1 Global Neurogenetic Testing Market Size Forecast by Type (2026-2035)
11.2 Global Neurogenetic Testing Market Forecast by Application (2026-2035)
11.2.1 Global Neurogenetic Testing Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neurogenetic Testing Market Size by Type (M USD)
Table 4. Global Neurogenetic Testing Market Size by Application
Table 5. Neurogenetic Testing Market Size Comparison by Region (M USD)
Table 6. Global Neurogenetic Testing Revenue (M USD) by Company (2020-2025)
Table 7. Global Neurogenetic Testing Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurogenetic Testing as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Neurogenetic Testing Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Neurogenetic Testing Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Neurogenetic Testing Market Size by Type (M USD)
Table 22. Global Neurogenetic Testing Market Size (M USD) by Type (2020-2025)
Table 23. Global Neurogenetic Testing Market Share by Type (2020-2025)
Table 24. Global Neurogenetic Testing Market Size Growth Rate by Type (2021-2025)
Table 25. Global Neurogenetic Testing Market Size by Application
Table 26. Global Neurogenetic Testing Market Size by Application (2020-2025) & (M USD)
Table 27. Global Neurogenetic Testing Market Share by Application (2020-2025)
Table 28. Global Neurogenetic Testing Market Size Growth Rate by Application (2021-2025)
Table 29. Global Neurogenetic Testing Market Size by Region (2020-2025) & (M USD)
Table 30. Global Neurogenetic Testing Market Size Market Share by Region (2020-2025)
Table 31. North America Neurogenetic Testing Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Neurogenetic Testing Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Neurogenetic Testing Market Size by Region (2020-2025) & (M USD)
Table 34. South America Neurogenetic Testing Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Neurogenetic Testing Market Size by Region (2020-2025) & (M USD)
Table 36. Quest Diagnostics Basic Information
Table 37. Quest Diagnostics Neurogenetic Testing Product Overview
Table 38. Quest Diagnostics Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Quest Diagnostics SWOT Analysis
Table 40. Quest Diagnostics Business Overview
Table 41. Quest Diagnostics Recent Developments
Table 42. Mayo Clinic Basic Information
Table 43. Mayo Clinic Neurogenetic Testing Product Overview
Table 44. Mayo Clinic Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Mayo Clinic SWOT Analysis
Table 46. Mayo Clinic Business Overview
Table 47. Mayo Clinic Recent Developments
Table 48. GeneDx Basic Information
Table 49. GeneDx Neurogenetic Testing Product Overview
Table 50. GeneDx Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 51. GeneDx SWOT Analysis
Table 52. GeneDx Business Overview
Table 53. GeneDx Recent Developments
Table 54. Illumina Basic Information
Table 55. Illumina Neurogenetic Testing Product Overview
Table 56. Illumina Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Illumina Business Overview
Table 58. Illumina Recent Developments
Table 59. Labcorp (Invitae/MNG Laboratories) Basic Information
Table 60. Labcorp (Invitae/MNG Laboratories) Neurogenetic Testing Product Overview
Table 61. Labcorp (Invitae/MNG Laboratories) Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Labcorp (Invitae/MNG Laboratories) Business Overview
Table 63. Labcorp (Invitae/MNG Laboratories) Recent Developments
Table 64. MedGenome Labs Basic Information
Table 65. MedGenome Labs Neurogenetic Testing Product Overview
Table 66. MedGenome Labs Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 67. MedGenome Labs Business Overview
Table 68. MedGenome Labs Recent Developments
Table 69. Connecticut Children's Basic Information
Table 70. Connecticut Children's Neurogenetic Testing Product Overview
Table 71. Connecticut Children's Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Connecticut Children's Business Overview
Table 73. Connecticut Children's Recent Developments
Table 74. CENTOGENE Basic Information
Table 75. CENTOGENE Neurogenetic Testing Product Overview
Table 76. CENTOGENE Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 77. CENTOGENE Business Overview
Table 78. CENTOGENE Recent Developments
Table 79. Victorian Clinical Genetics Services Basic Information
Table 80. Victorian Clinical Genetics Services Neurogenetic Testing Product Overview
Table 81. Victorian Clinical Genetics Services Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Victorian Clinical Genetics Services Business Overview
Table 83. Victorian Clinical Genetics Services Recent Developments
Table 84. PacBio Basic Information
Table 85. PacBio Neurogenetic Testing Product Overview
Table 86. PacBio Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 87. PacBio Business Overview
Table 88. PacBio Recent Developments
Table 89. Global Neurogenetic Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 90. North America Neurogenetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Europe Neurogenetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 92. Asia Pacific Neurogenetic Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America Neurogenetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Middle East and Africa Neurogenetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Global Neurogenetic Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 96. Global Neurogenetic Testing Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neurogenetic Testing Market Size by Type (M USD)
Table 4. Global Neurogenetic Testing Market Size by Application
Table 5. Neurogenetic Testing Market Size Comparison by Region (M USD)
Table 6. Global Neurogenetic Testing Revenue (M USD) by Company (2020-2025)
Table 7. Global Neurogenetic Testing Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurogenetic Testing as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Neurogenetic Testing Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Neurogenetic Testing Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Neurogenetic Testing Market Size by Type (M USD)
Table 22. Global Neurogenetic Testing Market Size (M USD) by Type (2020-2025)
Table 23. Global Neurogenetic Testing Market Share by Type (2020-2025)
Table 24. Global Neurogenetic Testing Market Size Growth Rate by Type (2021-2025)
Table 25. Global Neurogenetic Testing Market Size by Application
Table 26. Global Neurogenetic Testing Market Size by Application (2020-2025) & (M USD)
Table 27. Global Neurogenetic Testing Market Share by Application (2020-2025)
Table 28. Global Neurogenetic Testing Market Size Growth Rate by Application (2021-2025)
Table 29. Global Neurogenetic Testing Market Size by Region (2020-2025) & (M USD)
Table 30. Global Neurogenetic Testing Market Size Market Share by Region (2020-2025)
Table 31. North America Neurogenetic Testing Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Neurogenetic Testing Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Neurogenetic Testing Market Size by Region (2020-2025) & (M USD)
Table 34. South America Neurogenetic Testing Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Neurogenetic Testing Market Size by Region (2020-2025) & (M USD)
Table 36. Quest Diagnostics Basic Information
Table 37. Quest Diagnostics Neurogenetic Testing Product Overview
Table 38. Quest Diagnostics Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Quest Diagnostics SWOT Analysis
Table 40. Quest Diagnostics Business Overview
Table 41. Quest Diagnostics Recent Developments
Table 42. Mayo Clinic Basic Information
Table 43. Mayo Clinic Neurogenetic Testing Product Overview
Table 44. Mayo Clinic Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Mayo Clinic SWOT Analysis
Table 46. Mayo Clinic Business Overview
Table 47. Mayo Clinic Recent Developments
Table 48. GeneDx Basic Information
Table 49. GeneDx Neurogenetic Testing Product Overview
Table 50. GeneDx Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 51. GeneDx SWOT Analysis
Table 52. GeneDx Business Overview
Table 53. GeneDx Recent Developments
Table 54. Illumina Basic Information
Table 55. Illumina Neurogenetic Testing Product Overview
Table 56. Illumina Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Illumina Business Overview
Table 58. Illumina Recent Developments
Table 59. Labcorp (Invitae/MNG Laboratories) Basic Information
Table 60. Labcorp (Invitae/MNG Laboratories) Neurogenetic Testing Product Overview
Table 61. Labcorp (Invitae/MNG Laboratories) Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Labcorp (Invitae/MNG Laboratories) Business Overview
Table 63. Labcorp (Invitae/MNG Laboratories) Recent Developments
Table 64. MedGenome Labs Basic Information
Table 65. MedGenome Labs Neurogenetic Testing Product Overview
Table 66. MedGenome Labs Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 67. MedGenome Labs Business Overview
Table 68. MedGenome Labs Recent Developments
Table 69. Connecticut Children's Basic Information
Table 70. Connecticut Children's Neurogenetic Testing Product Overview
Table 71. Connecticut Children's Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Connecticut Children's Business Overview
Table 73. Connecticut Children's Recent Developments
Table 74. CENTOGENE Basic Information
Table 75. CENTOGENE Neurogenetic Testing Product Overview
Table 76. CENTOGENE Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 77. CENTOGENE Business Overview
Table 78. CENTOGENE Recent Developments
Table 79. Victorian Clinical Genetics Services Basic Information
Table 80. Victorian Clinical Genetics Services Neurogenetic Testing Product Overview
Table 81. Victorian Clinical Genetics Services Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Victorian Clinical Genetics Services Business Overview
Table 83. Victorian Clinical Genetics Services Recent Developments
Table 84. PacBio Basic Information
Table 85. PacBio Neurogenetic Testing Product Overview
Table 86. PacBio Neurogenetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 87. PacBio Business Overview
Table 88. PacBio Recent Developments
Table 89. Global Neurogenetic Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 90. North America Neurogenetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Europe Neurogenetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 92. Asia Pacific Neurogenetic Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America Neurogenetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Middle East and Africa Neurogenetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Global Neurogenetic Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 96. Global Neurogenetic Testing Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Neurogenetic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurogenetic Testing Market Size (M USD), 2025-2035
Figure 5. Global Neurogenetic Testing Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Neurogenetic Testing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Neurogenetic Testing Product Life Cycle
Figure 12. Global Neurogenetic Testing Revenue Share by Company in 2025
Figure 13. Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Neurogenetic Testing Revenue in 2025
Figure 15. Value Chain Map of Neurogenetic Testing
Figure 16. Global Neurogenetic Testing Market PEST Analysis
Figure 17. Global Neurogenetic Testing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Neurogenetic Testing Market Share by Type
Figure 20. Market Share of Neurogenetic Testing by Type (2020-2025)
Figure 21. Global Neurogenetic Testing Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neurogenetic Testing Market Share by Application
Figure 24. Global Neurogenetic Testing Market Share by Application (2020-2025)
Figure 25. Global Neurogenetic Testing Market Share by Application in 2024
Figure 26. Global Neurogenetic Testing Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Neurogenetic Testing Market Size Market Share by Region (2020-2025)
Figure 28. North America Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Neurogenetic Testing Market Size Market Share by Country in 2024
Figure 30. U.S. Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Neurogenetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Neurogenetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Neurogenetic Testing Market Share by Country in 2024
Figure 35. Germany Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Neurogenetic Testing Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Neurogenetic Testing Market Size Market Share by Region in 2024
Figure 42. China Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Neurogenetic Testing Market Size and Growth Rate (M USD)
Figure 48. South America Neurogenetic Testing Market Size Market Share by Country in 2024
Figure 49. Brazil Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Neurogenetic Testing Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Neurogenetic Testing Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Neurogenetic Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Neurogenetic Testing Market Share Forecast by Type (2026-2035)
Figure 61. Global Neurogenetic Testing Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Neurogenetic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurogenetic Testing Market Size (M USD), 2025-2035
Figure 5. Global Neurogenetic Testing Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Neurogenetic Testing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Neurogenetic Testing Product Life Cycle
Figure 12. Global Neurogenetic Testing Revenue Share by Company in 2025
Figure 13. Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Neurogenetic Testing Revenue in 2025
Figure 15. Value Chain Map of Neurogenetic Testing
Figure 16. Global Neurogenetic Testing Market PEST Analysis
Figure 17. Global Neurogenetic Testing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Neurogenetic Testing Market Share by Type
Figure 20. Market Share of Neurogenetic Testing by Type (2020-2025)
Figure 21. Global Neurogenetic Testing Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neurogenetic Testing Market Share by Application
Figure 24. Global Neurogenetic Testing Market Share by Application (2020-2025)
Figure 25. Global Neurogenetic Testing Market Share by Application in 2024
Figure 26. Global Neurogenetic Testing Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Neurogenetic Testing Market Size Market Share by Region (2020-2025)
Figure 28. North America Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Neurogenetic Testing Market Size Market Share by Country in 2024
Figure 30. U.S. Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Neurogenetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Neurogenetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Neurogenetic Testing Market Share by Country in 2024
Figure 35. Germany Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Neurogenetic Testing Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Neurogenetic Testing Market Size Market Share by Region in 2024
Figure 42. China Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Neurogenetic Testing Market Size and Growth Rate (M USD)
Figure 48. South America Neurogenetic Testing Market Size Market Share by Country in 2024
Figure 49. Brazil Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Neurogenetic Testing Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Neurogenetic Testing Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Neurogenetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Neurogenetic Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Neurogenetic Testing Market Share Forecast by Type (2026-2035)
Figure 61. Global Neurogenetic Testing Market Share Forecast by Application (2026-2035)
